Syngenta to Appeal Patent Verdict

Milwaukee biotech company secures venture capital

ZyStor Therapeutics Inc., a Milwaukee biotechnology company has secured $8.5 million in venture financing and plans to move into new offices in the Milwaukee County Research Park. The company's new laboratory and offices are under construction at the Technology Innovation Center in the park and are expected to be ready for occupancy in January. ZyStor develops innovative enzyme replacement therapies for the treatment of lysosomal storage diseases.

Full story.

Please visit our sponsor Gehrke & Associates, SC to learn more about how to enhance and defend your intellectual property.  Thank you.